PerkinElmer has successfully completed the divestiture of its Applied, Food and Enterprise Services businesses to New Mountain Capital. The resulting new Life Sciences and Diagnostics business will share the PerkinElmer name until a new name, brand and ticker symbol is unveiled in Q2 2023 pending shareholder approval. “Today marks the culmination of the hard work […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!